default search action

combined dblp search
author search
venue search
publication search

ask others

Stefan Laufer

> Home > Persons

Person information

Refine list

refinements active!

zoomed in on ?? of ?? records

view refined list in

export refined list as

showing all ?? records

Journal Articles

see FAQ

What is the meaning of the colors in the publication lists?

2023
[j3]
- view
  authority control:
- export record
  dblp key:
  - journals/jcisd/AntonPZLDGT23
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/journals/jcisd/AntonPZLDGT23
Débora Bublitz Anton, Júlia Galvez Bulhões Pedreira, Maria Luiza Zvirtes, Stefan Laufer, Rodrigo G. Ducati, Márcia Goettert, Luís Fernando S. M. Timmers:
Targeting SARS-CoV-2 Main Protease (MPro) with Kinase Inhibitors: A Promising Approach for Discovering Antiviral and Anti-inflammatory Molecules against SARS-CoV-2. J. Chem. Inf. Model. 63(13): 4138-4146 (2023)
2014
[j2]
- view
  authority control:
- export record
  dblp key:
  - journals/jcisd/SciorVGALW14
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/journals/jcisd/SciorVGALW14
Thomas Scior, Moritz Verhoff, Itzel Gutierrez-Aztatzi, Hermann P. T. Ammon, Stefan Laufer, Oliver Werz:
Interference of Boswellic Acids with the Ligand Binding Domain of the Glucocorticoid Receptor. J. Chem. Inf. Model. 54(3): 978-986 (2014)
2011
[j1]
- view
  authority control:
- export record
  dblp key:
  - journals/jcisd/SchattelHJZL11
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/journals/jcisd/SchattelHJZL11
Verena Schattel, Georg Hinselmann, Andreas Jahn, Andreas Zell, Stefan Laufer:
Modeling and Benchmark Data Set for the Inhibition of c-Jun N-terminal Kinase-3. J. Chem. Inf. Model. 51(3): 670-679 (2011)

manage site settings

To protect your privacy, all features that rely on external API calls from your browser are turned off by default. You need to opt-in for them to become active. All settings here will be stored as cookies with your web browser. For more information see our F.A.Q.